Ardelyx IncNASDAQ:ARDX
- LAST PRICE5.6200
- TODAY'S CHANGE (%)0.1300 (2.3679%)
- Bid / Lots5.6100/ 2
- Ask / Lots5.6500/ 38
- Open / Previous Close5.5500 / 5.4900
- Day Range
- 52 Week Range
- Volume3,954,730
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ARDX |
|---|---|---|
| 09:32 ET | 41412 | 5.56 |
| 09:34 ET | 111221 | 5.575 |
| 09:36 ET | 25174 | 5.615 |
| 09:38 ET | 30727 | 5.685 |
| 09:39 ET | 22586 | 5.655 |
| 09:41 ET | 26059 | 5.5942 |
| 09:43 ET | 6720 | 5.63 |
| 09:45 ET | 12052 | 5.68 |
| 09:48 ET | 9364 | 5.6989 |
| 09:50 ET | 25655 | 5.7 |
| 09:52 ET | 16342 | 5.7168 |
| 09:54 ET | 72818 | 5.722 |
| 09:56 ET | 32411 | 5.7 |
| 09:57 ET | 11795 | 5.68 |
| 09:59 ET | 31380 | 5.66 |
| 10:01 ET | 19298 | 5.68 |
| 10:03 ET | 22907 | 5.62 |
| 10:06 ET | 20707 | 5.67 |
| 10:08 ET | 37830 | 5.615 |
| 10:10 ET | 31640 | 5.58 |
| 10:12 ET | 10425 | 5.625 |
| 10:14 ET | 17613 | 5.61 |
| 10:15 ET | 37333 | 5.575 |
| 10:17 ET | 37899 | 5.58 |
| 10:19 ET | 25165 | 5.5501 |
| 10:21 ET | 12749 | 5.535 |
| 10:24 ET | 5984 | 5.525 |
| 10:26 ET | 12937 | 5.505 |
| 10:28 ET | 51917 | 5.495 |
| 10:30 ET | 26034 | 5.495 |
| 10:32 ET | 34082 | 5.4702 |
| 10:33 ET | 135632 | 5.45 |
| 10:35 ET | 26986 | 5.445 |
| 10:37 ET | 67267 | 5.466 |
| 10:39 ET | 32484 | 5.47 |
| 10:42 ET | 5585 | 5.505 |
| 10:44 ET | 1000 | 5.51 |
| 10:46 ET | 1558 | 5.5 |
| 10:48 ET | 18101 | 5.516 |
| 10:50 ET | 24052 | 5.505 |
| 10:51 ET | 32049 | 5.5001 |
| 10:53 ET | 44088 | 5.53 |
| 10:55 ET | 22080 | 5.5102 |
| 10:57 ET | 10538 | 5.51 |
| 11:00 ET | 17645 | 5.515 |
| 11:02 ET | 36079 | 5.53 |
| 11:04 ET | 19446 | 5.5099 |
| 11:06 ET | 2127 | 5.5 |
| 11:08 ET | 1343 | 5.505 |
| 11:09 ET | 30588 | 5.51 |
| 11:11 ET | 31049 | 5.505 |
| 11:13 ET | 14746 | 5.515 |
| 11:15 ET | 31665 | 5.5 |
| 11:18 ET | 25263 | 5.51 |
| 11:20 ET | 13500 | 5.505 |
| 11:22 ET | 41104 | 5.4902 |
| 11:24 ET | 12200 | 5.495 |
| 11:26 ET | 6580 | 5.495 |
| 11:27 ET | 27234 | 5.515 |
| 11:29 ET | 19128 | 5.5301 |
| 11:31 ET | 28756 | 5.54 |
| 11:33 ET | 58263 | 5.555 |
| 11:36 ET | 21843 | 5.5563 |
| 11:38 ET | 9797 | 5.55 |
| 11:40 ET | 6420 | 5.56 |
| 11:42 ET | 4507 | 5.57 |
| 11:44 ET | 86075 | 5.56 |
| 11:45 ET | 6725 | 5.55 |
| 11:47 ET | 16919 | 5.58 |
| 11:49 ET | 21234 | 5.58 |
| 11:51 ET | 18220 | 5.575 |
| 11:54 ET | 18064 | 5.5799 |
| 11:56 ET | 21684 | 5.585 |
| 11:58 ET | 22906 | 5.57 |
| 12:00 ET | 36142 | 5.585 |
| 12:02 ET | 19221 | 5.59 |
| 12:03 ET | 15615 | 5.58 |
| 12:05 ET | 10310 | 5.595 |
| 12:07 ET | 27635 | 5.585 |
| 12:09 ET | 13475 | 5.58 |
| 12:12 ET | 23536 | 5.56 |
| 12:14 ET | 3857 | 5.55 |
| 12:16 ET | 19701 | 5.5673 |
| 12:18 ET | 2458 | 5.565 |
| 12:20 ET | 2801 | 5.57 |
| 12:21 ET | 6503 | 5.555 |
| 12:23 ET | 700 | 5.55 |
| 12:25 ET | 12626 | 5.55 |
| 12:27 ET | 2137 | 5.55 |
| 12:30 ET | 3539 | 5.55 |
| 12:32 ET | 871 | 5.555 |
| 12:34 ET | 6331 | 5.55 |
| 12:36 ET | 6640 | 5.535 |
| 12:38 ET | 14949 | 5.525 |
| 12:39 ET | 2100 | 5.52 |
| 12:41 ET | 6467 | 5.52 |
| 12:43 ET | 3295 | 5.54 |
| 12:45 ET | 6100 | 5.54 |
| 12:48 ET | 3700 | 5.545 |
| 12:50 ET | 16069 | 5.51 |
| 12:52 ET | 12915 | 5.515 |
| 12:54 ET | 5200 | 5.51 |
| 12:56 ET | 13947 | 5.5101 |
| 12:57 ET | 10800 | 5.514 |
| 12:59 ET | 4658 | 5.525 |
| 01:01 ET | 3511 | 5.535 |
| 01:03 ET | 1100 | 5.535 |
| 01:06 ET | 5189 | 5.535 |
| 01:08 ET | 9038 | 5.525 |
| 01:10 ET | 2100 | 5.535 |
| 01:12 ET | 300 | 5.535 |
| 01:14 ET | 76085 | 5.565 |
| 01:15 ET | 7011 | 5.57 |
| 01:17 ET | 6602 | 5.575 |
| 01:19 ET | 6149 | 5.585 |
| 01:21 ET | 2907 | 5.58 |
| 01:24 ET | 800 | 5.585 |
| 01:26 ET | 4918 | 5.6 |
| 01:28 ET | 1089 | 5.6 |
| 01:30 ET | 7862 | 5.61 |
| 01:32 ET | 18000 | 5.62 |
| 01:33 ET | 5498 | 5.625 |
| 01:35 ET | 15553 | 5.59 |
| 01:37 ET | 2969 | 5.595 |
| 01:39 ET | 317 | 5.595 |
| 01:42 ET | 7363 | 5.61 |
| 01:44 ET | 11982 | 5.58 |
| 01:46 ET | 11658 | 5.605 |
| 01:48 ET | 1498 | 5.62 |
| 01:50 ET | 2900 | 5.615 |
| 01:51 ET | 1300 | 5.62 |
| 01:53 ET | 2800 | 5.615 |
| 01:55 ET | 7427 | 5.62 |
| 01:57 ET | 3645 | 5.61 |
| 02:00 ET | 2335 | 5.615 |
| 02:02 ET | 4476 | 5.625 |
| 02:04 ET | 5767 | 5.625 |
| 02:06 ET | 4447 | 5.615 |
| 02:08 ET | 6563 | 5.625 |
| 02:09 ET | 3612 | 5.635 |
| 02:11 ET | 7700 | 5.635 |
| 02:13 ET | 7669 | 5.635 |
| 02:15 ET | 2680 | 5.635 |
| 02:18 ET | 6960 | 5.62 |
| 02:20 ET | 7435 | 5.595 |
| 02:22 ET | 3200 | 5.585 |
| 02:24 ET | 13702 | 5.605 |
| 02:26 ET | 10625 | 5.625 |
| 02:27 ET | 9948 | 5.615 |
| 02:29 ET | 8017 | 5.615 |
| 02:31 ET | 1564 | 5.615 |
| 02:33 ET | 5916 | 5.6 |
| 02:36 ET | 4975 | 5.61 |
| 02:38 ET | 3981 | 5.605 |
| 02:40 ET | 6788 | 5.6 |
| 02:42 ET | 3816 | 5.595 |
| 02:44 ET | 12567 | 5.6 |
| 02:45 ET | 20316 | 5.59 |
| 02:47 ET | 3098 | 5.59 |
| 02:49 ET | 3061 | 5.595 |
| 02:51 ET | 1655 | 5.6 |
| 02:54 ET | 6462 | 5.595 |
| 02:56 ET | 1427 | 5.595 |
| 02:58 ET | 10963 | 5.595 |
| 03:00 ET | 1024 | 5.59 |
| 03:02 ET | 9900 | 5.585 |
| 03:03 ET | 4607 | 5.585 |
| 03:05 ET | 4457 | 5.575 |
| 03:07 ET | 5148 | 5.585 |
| 03:09 ET | 2867 | 5.595 |
| 03:12 ET | 3060 | 5.605 |
| 03:14 ET | 6810 | 5.605 |
| 03:16 ET | 12235 | 5.6 |
| 03:18 ET | 26223 | 5.595 |
| 03:20 ET | 1400 | 5.6 |
| 03:21 ET | 600 | 5.59 |
| 03:23 ET | 18611 | 5.615 |
| 03:25 ET | 2400 | 5.615 |
| 03:27 ET | 21908 | 5.615 |
| 03:30 ET | 4284 | 5.615 |
| 03:32 ET | 15527 | 5.615 |
| 03:34 ET | 24847 | 5.59 |
| 03:36 ET | 3434 | 5.585 |
| 03:38 ET | 26252 | 5.605 |
| 03:39 ET | 13683 | 5.595 |
| 03:41 ET | 2660 | 5.595 |
| 03:43 ET | 25242 | 5.585 |
| 03:45 ET | 13881 | 5.59 |
| 03:48 ET | 4162 | 5.59 |
| 03:50 ET | 26808 | 5.595 |
| 03:52 ET | 31041 | 5.59 |
| 03:54 ET | 23525 | 5.6 |
| 03:56 ET | 51539 | 5.62 |
| 03:57 ET | 51282 | 5.625 |
| 03:59 ET | 53829 | 5.62 |
Jul 18, 2024
DJ Ardelyx Price Target Maintained With a $10.00/Share by HC Wainwright & Co., from 3:13PM ET on Thursday Jul 18, 2024 by Dow Jones
3:13PM ET on Thursday Jul 18, 2024 by Dow JonesArdelyx to Report Second Quarter 2024 Financial Results on August 1, 2024, from 8:00AM ET on Thursday Jul 18, 2024 by Dow Jones
8:00AM ET on Thursday Jul 18, 2024 by Dow Jones
Jul 17, 2024
*DJ Ardelyx, Others File Lawsuit Against HHS, Centers for Medicare and Medicaid Services >ARDX, from 5:13PM ET on Wednesday Jul 17, 2024 by Dow Jones
5:13PM ET on Wednesday Jul 17, 2024 by Dow JonesArdelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines, from 5:10PM ET on Wednesday Jul 17, 2024 by Dow Jones
5:10PM ET on Wednesday Jul 17, 2024 by Dow Jones
Jul 3, 2024
DJ Ardelyx Is Maintained at Buy by Citigroup, from 2:15PM ET on Wednesday Jul 03, 2024 by Dow Jones
2:15PM ET on Wednesday Jul 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ardelyx Inc | 1.3B | -19.5x | --- |
Gyre Therapeutics Inc | 1.3B | -8.0x | --- |
Arcus Biosciences Inc | 1.4B | -5.1x | --- |
Prothena Corporation PLC | 1.3B | -7.5x | --- |
Xencor Inc | 1.3B | -9.9x | --- |
Nurix Therapeutics Inc | 1.4B | -7.5x | --- |
Company Information
Ardelyx, Inc. is a biopharmaceutical company. The Company focuses on discovery, development, and commercialization of advanced medicines that meet significant unmet medical needs. It has two commercial products IBSRELA (tenapanor) and XPHOZAH. Its product pipeline includes RDX013 Program and RDX020 Program. Tenapanor is a small molecule therapy in development for the treatment of or the control of hyperphosphatemia or serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Tenapanor has a mechanism of action and acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3). IBSRELA is developed for the treatment of patients with irritable bowel syndrome with constipation (IBS-C). XPHOZAH is a medicine for the control of serum phosphorus in adult patients with CKD on dialysis. RDX013 Program is a small molecule potassium secretagogue program for the treatment of hyperkalemia. RDX020 Program is a small molecule for treating metabolic acidosis.
Contact Information
- Headquarters
- 34175 Ardenwood BlvdFREMONT, CA, United States 94555-3653
- Phone
- 510-745-7047
- Fax
- 510-745-0493
Executives
- Independent Chairman of the Board
- David Mott
- President, Chief Executive Officer, Director
- Michael Raab
- Chief Financial and Operations Officer
- Justin Renz
- Executive Vice President, Corporate Development and Strategy
- Mike Kelliher
- Chief Legal and Administrative Officer
- Elizabeth Grammer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3B |
|---|---|
Revenue (TTM) | $159.1M |
Shares Outstanding | 234.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.86 |
EPS | $-0.29 |
Book Value | $0.72 |
P/E Ratio | -19.5x |
Price/Sales (TTM) | 8.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -38.90% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
